Detalhe da pesquisa
1.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
N Engl J Med
; 389(20): 1851-1861, 2023 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37870969
2.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
N Engl J Med
; 383(9): 825-835, 2020 08 27.
Artigo
Inglês
| MEDLINE | ID: mdl-32846061
3.
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial.
Cancer
; 128(12): 2281-2287, 2022 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35380178
4.
Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
Cancer
; 128(11): 2193-2204, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35139236
5.
Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit.
Oncologist
; 27(7): 565-572, 2022 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35482606
6.
Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 Trial.
Oncologist
; 27(1): 22-29, 2022 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34523767
7.
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial.
Oncologist
; 27(1): 13-21, 2022 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34516023
8.
Phase II Study of Cabozantinib in Patients With Bone Metastasis.
Oncologist
; 27(7): 600-606, 2022 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35524758
9.
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
Oncologist
; 27(11): 930-939, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35852437
10.
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(8): 925-951, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35948029
11.
LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer.
Future Oncol
; 18(28): 3143-3150, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35969032
12.
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Mod Pathol
; 33(12): 2458-2472, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32737449
13.
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment.
Invest New Drugs
; 38(6): 1774-1783, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32410080
14.
Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer.
Int J Cancer
; 144(9): 2266-2278, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30515783
15.
Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.
Oncologist
; 24(10): 1356-1367, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30926674
16.
Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model.
Cancer Immunol Immunother
; 68(8): 1273-1286, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31243491
17.
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
Cancer
; 124(11): 2365-2372, 2018 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29656442
18.
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
N Engl J Med
; 372(7): 621-30, 2015 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-25671254
19.
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
J Natl Compr Canc Netw
; 16(12): 1429-1440, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30545990
20.
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
Cancer
; 123(14): 2642-2650, 2017 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28222215